Home › Kanser sa Prostate › Colorado › Denver
Pag-aaral pangklinika para sa Kanser sa Prostate sa Denver, CO
19 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Denver (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Kaiser Permanente-Franklin, Denver
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Nagre-recruitPhase 1/2
- GSK Investigational Site, Denver
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute at HealthOne, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Rocky Mountain Cancer Center, Denver
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Nagre-recruitPhase 3
- Kaiser Permanente-Franklin, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- AdventHealth Porter, Denver
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Nagre-recruitPhase 1/2
- Sarah Cannon Research Institute 1, Denver
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Nagre-recruitPhase 3
- AdventHealth Medical Group Urology of Denver, Denver
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Nagre-recruitPhase 2/3
- Rocky Mountain Cancer Centers, Denver
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Nagre-recruitPhase 3
- Rocky Mountain Cancer Centers, Denver
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Nagre-recruitPhase 3
- Rocky Mountain Cancer Centers, Denver
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Nagre-recruitPhase 1
- Rocky Mountain Cancer Centers, Denver
- United States Oncology Regulatory Affairs Corporate Office, Denver
- US Oncology Research Investigational Products Center, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nagre-recruitPhase 1
- Sarah Cannon Research Institute - Denver DDU, Denver
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Nagre-recruitPhase 3
- UCHealth - Cherry Creek, Denver
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
Nagre-recruitMaagang Phase 1
- UCHealth-Metro Denver, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Sarah Cannon Research Institute, Denver
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Nagre-recruitPhase 2
- Porter Adventist Hospital, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Denver
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- Porter Adventist Hospital, Denver
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN43 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Denver
- Metastatic Cancer29 pag-aaral
- Kanser sa Suso29 pag-aaral
- Non-Small Cell Lung Cancer27 pag-aaral
- Multiple Myeloma27 pag-aaral
- Colorectal Cancer23 pag-aaral
- Melanoma19 pag-aaral
- Kanser (lahat ng uri)18 pag-aaral
- Kanser sa Ovary16 pag-aaral
- Kanser sa Baga16 pag-aaral
- Kanser ng Endometrium15 pag-aaral
- Non-Hodgkin Lymphoma14 pag-aaral
- Kanser sa Pancreas13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.